Skip to main content
TipRanks
Go Ultimate75% OFF

Dr. Martens Plc (DOCS) Share Price & Analysis

153 Followers

DOCS Stock Chart & Stats

GBX 54.50-GBX 1.60(-2.85%)
At close: 4:30 PM GMT
60 p70 p80 pAug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
GBX 54.50 - GBX 57.00
52-Week Range
GBX 50.80 - GBX 90.00
Previous Close
GBX 56.10
Volume
N/A
Average Volume (3M)
2.25M
Market Cap
GBP 533.24M
Enterprise Value
GBP 952.18M
Total Cash (Recent Filing)
GBP 91.10M
Total Debt (Recent Filing)
GBP 400.90M
Price to Earnings (P/E)
19.3
Beta
1.39
Next Earnings
Jun 03, 2027 (Est.)
Dividend Yield
4.55%

Bulls Say, Bears Say

Bulls Say

Cash Generation And Conversion

Solid free cash flow and close alignment with operating cash flow indicate effective earnings conversion and support ongoing investment, debt service, and shareholder distributions. This provides financial resilience while management works to restore revenue growth, although yearly cash generation remains somewhat volatile.

Margin Resilience And Cost Control

Cost actions, a simplified operating model, and disciplined pricing helped offset lower volumes and preserve profitability. Sustained control of operating expenses and gross margin can protect cash generation and create operating leverage if product demand improves over the next several quarters.

Brand And Product Development

Growth in shoes and sandals, alongside broad global brand activation, shows that demand is not limited to the core boot franchise. Expanding product categories and reinforcing brand engagement could diversify revenue and support longer-term growth as the company rebuilds its footwear portfolio.

Bears Say

Multi-year Revenue And Profit Deterioration

Persistent revenue contraction and materially lower profitability indicate that the business has not yet restored its prior earnings power. Even with a 2026 operating-margin rebound, weaker scale and compressed net returns reduce reinvestment capacity and leave performance dependent on successful recovery.

Core Boots Weakness

The core boot franchise remains the principal drag on sales, with management acknowledging that recovery will take time. Because boots are central to the brand proposition, prolonged weakness can limit overall growth, dilute operating leverage, and force newer categories to compensate before the core business stabilizes.

DTC Disruption And Execution Risk

Direct-to-consumer performance and the platform transition require continued disciplined execution, affecting an important route to market and customer experience. Ongoing disruption could delay sales recovery, weaken channel productivity, and make the company more reliant on wholesale while digital operations mature.

Dr. Martens Plc News

DOCS FAQ

What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest share price was 50.80 p and its highest was 90.00 p in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is £533.24M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s next earnings report is estimated for Jun 03, 2027 (not yet confirmed), which is in 195 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on Nov 12, 2026. The company reported -0.01 p earnings per share for the quarter, missing the consensus estimate of -0.005 p by -0.005 p.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a semiannual dividend of 0.85 p which represents an annual dividend yield of 4.55%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is 0.05.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 968,121,300 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of -0.01 p in its last earnings report, missing expectations of -0.005 p. Following the earnings report the stock price went down -14.669%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in GB:DOCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology